MILLICENT MARWA: Open Payments
NPI 1295983203 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $48 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Almatica Pharma LLC | 1 | $16 |
Products named: ZEPBOUND, Qelbree, AUSTEDO XR, CAPLYTA, LOREEV XR.
Industry payments across MN — which companies pay providers there.
